NUFLOR DIN 02216558
Health Canada record
| Active ingredient(s) | FLORFENICOL 300 MG |
|---|---|
| Dosage form | Solution |
| Route | Intramuscular; Subcutaneous |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 25-Oct-1996 |
| Current status date | 04-Dec-2013 |
| Source | Health Canada DPD |
Establishment licence of the holder
Intervet Canada Corp. — licence 100147, currently licensed, last inspection rating C (2023-07-17).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FLORFENICOL
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02231742 | AQUAFLOR | INTERVET CANADA CORP | Drug Premix | FLORFENICOL 500 G | Marketed |
| 02472953 | CLARO | ELANCO CANADA LIMITED | Solution | FLORFENICOL 16.6 MG; TERBINAFINE (TERBINAFINE HYDROCHLORIDE) 14.8 MG; MOMETASONE FUROATE 2.2 MG | Marketed |
| 02497166 | FENISOLVE | NORBROOK LABORATORIES LTD. | Solution | FLORFENICOL 300 MG | Marketed |
| 02458527 | FLORKEM | CEVA ANIMAL HEALTH INC | Solution | FLORFENICOL 300 MG | Marketed |
| 02526654 | PAQ FLOR | PHIBRO ANIMAL HEALTH CORPORATION | Drug Premix | FLORFENICOL 500 G | Marketed |
| 02330997 | RESFLOR | INTERVET CANADA CORP | Solution | FLORFENICOL 300 MG; FLUNIXIN (FLUNIXIN MEGLUMINE) 16.5 MG | Marketed |
| 02555670 | SIMPLERA | VETOQUINOL N A INC | Solution | FLORFENICOL 16.6 MG; TERBINAFINE HYDROCHLORIDE 16.6 MG; MOMETASONE FUROATE 2.2 MG | Marketed |
| 02501015 | ZELERIS | CEVA ANIMAL HEALTH INC | Solution | FLORFENICOL 400 MG; MELOXICAM 5 MG | Marketed |
| 02287803 | NUFLOR | INTERVET CANADA CORP | Solution | FLORFENICOL 23 MG | Cancelled Post Market |
| 02339579 | NUFLOR 4% PREMIX | INTERVET CANADA CORP | Drug Premix | FLORFENICOL 40 G | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 10442 | 2009-07-23 | New Drug Submission (NDS) | Change in ownership |
| 8473 | 2006-12-19 | Supplement to a New Drug Submission (SNDS) | NEW CLAIM FOR CATTLE |
| 5349 | 2004-09-13 | Supplement to a New Drug Submission (SNDS) | NEW SPECIES: SWINE - TREATMENT OF SWINE RESPIRATORY DISEASE ASSOCIATED WITH ACTINOBACILLUS PLEUROPNEUMONIAE AND PASTEURELLA MULTOCIDA |
| 6080 | 2002-07-05 | Supplement to a New Drug Submission (SNDS) | NEW INDICATION: TREATMENT OF BOVINE INTERDIGITAL PHLEGMON (FOOT ROT, INTERDIGITAL NECROBACILLOSIS, INFECTIOUS PODODERMATITIS) ASSOCIATED WITH FUSOBACTERIUM NECROPHORUM AND BACTEROIDES MELANINOGENICUS |
| 6081 | 2002-07-05 | Supplement to a New Drug Submission (SNDS) | NEW INDICATION: TREATMENT OF INFECTIOUS BOVINE KERATOCONJUNCTIVITIS (IBK, PINKEYE) CAUSED BY MORAXELLA BOVIS |
| 6584 | 1999-03-31 | Supplement to a New Drug Submission (SNDS) | ADDITION OF A SUBCUTANEOUS ROUTE OF ADMINISTRATION |
| 6852 | 1998-09-02 | Supplement to a New Drug Submission (SNDS) | TO PROVIDE FOR AN EXTENSION IN THE CLAIM: FOR THE TREATMENT OF BOVINE RESPIRATORY DISEASE COMPLEX, ALSO CALLED SHIPPING FEVER, ASSOCIATED WITH PASTEURELLA HAEMOLYTICA, PASTEURELLA MULTOCIDA AND HAEMOPHILUS SOMNUS |
| 7041 | 1996-04-03 | New Drug Submission (NDS) |